Dominant/JJ
cytotoxic/JJ
T/NN
lymphocyte/NN
response/NN
to/TO
the/DT
immediate-early/JJ
trans-activator/JJ
protein/NN
,/,
BZLF1/NN
,/,
in/IN
persistent/JJ
type/NN
A/NN
or/CC
B/NN
Epstein-Barr/JJ
virus/NN
infection/NN
./.

Five/CD
healthy/JJ
human/JJ
leukocyte/NN
antigen-B8/NN
(/(
HLA-B8/NN
)/)
-positive/JJ
virus/NN
carriers/NNS
were/VBD
studied/VBN
to/TO
investigate/VB
the/DT
CD8+/JJ
cytotoxic/JJ
T/NN
lymphocyte/NN
(/(
CTL/NN
)/)
response/NN
to/TO
an/DT
HLA-B8-restricted/JJ
peptide/NN
,/,
RAKFKQLLQ/NN
,/,
located/JJ
in/IN
the/DT
Epstein-Barr/JJ
virus/NN
(/(
EBV/NN
)/)
immediate-early/JJ
trans-activator/NN
protein/NN
,/,
BZLF1/NN
./.
=====
Of/IN
the/DT
5/CD
virus/NN
carriers/NNS
,/,
4/CD
were/VBD
infected/VBN
with/IN
type/NN
A/NN
and/CC
1/CD
with/IN
type/NN
B/NN
EBV/NN
./.
=====
Using/VBG
limiting-dilution/JJ
analysis/NN
of/IN
peripheral/JJ
blood/NN
mononuclear/JJ
cells/NNS
,/,
a/DT
high/JJ
RAKFKQLLQ-specific/JJ
CTL/NN
precursor/NN
frequency/NN
was/VBD
demonstrated/VBN
after/IN
specific/JJ
peptide/NN
or/CC
autologous/JJ
lymphoblastoid/JJ
cell/NN
line/NN
stimulation/NN
in/IN
both/CC
type/NN
A/NN
and/CC
type/NN
B/NN
EBV/NN
carriers/NNS
./.
=====
The/DT
RAKFKQLLQ-specific/JJ
CTL/NN
precursor/NN
frequencies/NNS
in/IN
all/DT
5/CD
persons/NNS
were/VBD
at/IN
least/JJS
as/RB
dominant/JJ
as/IN
those/DT
observed/VBN
with/IN
two/CD
other/JJ
EBV-associated/JJ
,/,
HLA-B8-restricted/JJ
latent/JJ
epitopes/NNS
,/,
FLRGRAYGL/NN
and/CC
QAKWRLQTL/NN
./.
=====
These/DT
findings/NNS
show/VBP
that/IN
healthy/JJ
virus/NN
carriers/NNS
maintain/VBP
a/DT
high/JJ
frequency/NN
of/IN
BZLF1-specific/JJ
memory/NN
T/NN
cells/NNS
,/,
potentially/RB
to/TO
control/VB
virus/NN
spread/VBN
from/IN
lytically/RB
infected/JJ
cells/NNS
./.